drugset / Trial / NCT01138735
Epiduo Pediatric Acne Study
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% administered once daily for up to 12 weeks in subjects 9 to 11 years of age with acne vulgaris.
Timeline
- Start
- 2010-06
- Primary completion
- 2011-08
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adapalene | Other / unclassified | 0.1 % | Topical |
| Comparator | Benzoyl Peroxide | Other / unclassified | 2.5 % | Topical |